News

Curiox Biosystems Unveils Advanced C-Free Pluto ALPHA Device

Curiox Biosystems Unveils Advanced C-Free Pluto ALPHA Device

Curiox Biosystems Introduces an Innovative Cell Washing Solution

Curiox Biosystems, renowned for pioneering automated sample preparation platforms, is thrilled to announce the launch of the Curiox C-Free Pluto ALPHA. This new device represents a significant leap forward in cell washing automation, providing a compact, intuitive solution suited for laboratories of various sizes.

Transforming Cell Washing Methods

The Curiox C-Free Pluto ALPHA shifts away from traditional centrifuge-based approaches, which can be cumbersome and time-consuming. This innovative device employs an advanced pipette head system that delivers gentle and consistent washing of suspension cells and beads, ensuring that sample integrity remains intact while enhancing reproducibility. As a result, researchers can expect to achieve more consistent outcomes across their experiments while saving precious time.

Key Features That Stand Out

The Curiox C-Free Pluto ALPHA boasts a variety of unique features designed to optimize laboratory workflows:

  • Gentle Washing: The pipette-based technology utilized in the Curiox C-Free Pluto ALPHA expertly preserves cell viability, avoiding the damage often caused by centrifugation.
  • Effortless Integration: Its compact design allows for easy incorporation into existing laboratory setups without the need for further infrastructure.
  • Labware Compatibility: This cutting-edge device works seamlessly with 96-well plates, deep-well plates, and Laminar Wash plates, making it highly adaptable.
  • Minimal Maintenance: With maintenance requirements akin to those of a standard pipetting station, labs can expect reduced downtime and lower operational costs.
  • Affordable Automation: With a price tag of under $30,000, this system offers a budget-friendly option for labs looking to enhance their operations.
  • Compact Footprint: Its small size is ideal for optimizing valuable laboratory bench space.

Workflow Enhancements

The pre-configured settings for Light, Moderate, Heavy, and Ultra wash protocols significantly decrease the hands-on time required for researchers, enabling them to dedicate themselves to more critical tasks. Eliminating centrifuge-related steps provides smoother workflows while maintaining experiment reproducibility, especially beneficial in fields like immunophenotyping, cell therapy, and drug discovery.

Empowering Research with the Pluto Line

The Curiox Pluto product line exemplifies the company's dedication to fostering innovation within research settings. By emphasizing scalability and adaptability, these devices cater to a wide range of research and clinical applications. The Curiox C-Free Pluto ALPHA is an essential advancement for any laboratory looking to enhance their cell washing processes

Customizable Configurations

This remarkable device allows for various model configurations:

  • Standard Model: Features a fixed 96-channel pipette head and three plate decks, enabling wash cycles starting from just 2 minutes.
  • Custom Options: Users have the flexibility to configure pipette tips and wash parameters to meet specific workflow demands.

Experience the Curiox C-Free Pluto ALPHA

As per Dr. Namyong Kim, CEO & CTO of Curiox Biosystems, "The Curiox C-Free Pluto ALPHA perfectly combines affordability, simplicity, and precision. This device empowers labs of varying sizes to achieve reliable results efficiently while conserving resources. Our commitment to accessible automation is boldly represented in this product." Curiox encourages industry leaders and researchers to witness the transformative potential of the C-Free Pluto ALPHA firsthand at SLAS2025, where attendees can learn more at booth #113.

About Curiox Biosystems Co. Ltd

Curiox Biosystems Co. Ltd is a rapidly advancing biotechnology firm dedicated to creating cutting-edge sample preparation solutions to propel next-generation therapy developments. Focused on addressing challenges in life sciences research through their innovative surface chemistry and instrumentation expertise, Curiox's solutions significantly enhance lab productivity and accelerate therapeutic advancements. Their dedication to the proprietary C-FREE™ technology positions them as a vital contributor to the evolution of life sciences research and diagnostics worldwide.

For additional inquiries or information, researchers can directly contact:

[Mahrukh M Banday, PhD]
[Executive Vice President / General Manager]
[+17814915289]

Frequently Asked Questions

What is the Curiox C-Free Pluto ALPHA?

The Curiox C-Free Pluto ALPHA is an automated device designed for cell washing, streamlining laboratory workflows and enhancing sample integrity.

How does the C-Free Pluto ALPHA improve cell washing?

It employs a gentle pipette-based washing technique that avoids centrifugation, thereby preserving cell viability and improving reproducibility.

What are the key features of this device?

Key features include gentle washing technology, effortless integration, compatibility with various labware, minimal maintenance requirements, and an affordable price point.

Can the device be customized for specific lab needs?

Yes, the C-Free Pluto ALPHA offers customizable configurations, including various pipette tips and wash parameters tailored to individual laboratory workflows.

Where can I learn more about the Curiox C-Free Pluto ALPHA?

You can discover more about the C-Free Pluto ALPHA and see live demonstrations at industry events, such as SLAS2025 or through official Curiox communications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Cytokinetics Faces Class Action: What You Need to Know

Updated Category News Views 175

Understanding the Class Action Lawsuit Against Cytokinetics Cytokinetics, Incorporated is currently facing a significant class action lawsuit initiated by shareholders. This legal challenge brings to light serious allegations against the Company regarding their disclosures and expectations for FDA approval of a key drug. Details of the Allegations The lawsuit asserts that...

Continue Reading
Discover the Embodied Luxury of the Champagne Specialist Course

Updated Category News Views 207

Verona Hosts the Esteemed Champagne Specialist Course The Italian Wine Academy is excited to announce a remarkable opportunity for wine enthusiasts and professionals. In Verona, for the very first time, the Academy will conduct the prestigious Comité Champagne 'Champagne Specialist' course. This unique program will be available in both English and Italian, providing an...

Continue Reading
MiniLuxe Achieves Strong Q1 2025 Growth with Strategic Focus

Updated Category News Views 378

MiniLuxe Reports Strong Financial Performance for Q1 2025 Reported figures all in U.S. Dollars MiniLuxe Holding Corp. (TSXV: MNLX) has announced exciting financial results for its first quarter of the year. This period showcased a significant 9% growth in revenue, reaching an impressive $6.1 million. Coupled with a gross profit of $2.5 million, reflective of a 12%...

Continue Reading
Transforming Shopify: AI Product Discovery for Enterprises

Updated Category News Views 141

Fredhopper's New App for Shopify Fredhopper Introduces Cutting-Edge Product Discovery Solutions The ecommerce landscape is evolving rapidly, and innovation is at the forefront. Fredhopper has launched its Product Discovery App for Shopify, bringing advanced AI-powered product search and personalized recommendations directly into the hands of enterprise merchants. This...

Continue Reading
Quantum Computing Inc. Faces Class Action Lawsuit for Shareholders

Updated Category News Views 162

Understanding the Recent Class Action Against Quantum Computing Inc. In a significant turn of events, Quantum Computing Inc. has come under legal pressure as a class action lawsuit has been filed on behalf of its shareholders. The lawsuit comes in response to allegations of misleading information that may have adversely affected investors' financial interests. Class...

Continue Reading